Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
05/03/2007 | US20070098734 loading antigen presenting cells from a subject; loading antigen presenting cells (APC's) having Class I MHC (major histocompatibility factor) molecules with T cell epitopes; culturing CD8+ T cells with APC's; expanding in culture; for allergic asthma, insulin dependent diabetes, arthritis |
05/03/2007 | US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer |
05/03/2007 | DE102005047946A1 Verwendung von Aktivatoren der löslichen Guanylatzyklase zur Behandlung von akuten und chronischen Lungenkrankheiten Use of activators of soluble guanylate cyclase for the treatment of acute and chronic lung diseases |
05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
05/03/2007 | CA2627485A1 Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein |
05/03/2007 | CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity |
05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
05/02/2007 | EP1778673A1 Novel hydantoin derivatives for the treatment of obstructive airway diseases |
05/02/2007 | EP1778672A1 Crystalline form of a biphenyl compound |
05/02/2007 | EP1778638A1 Diaryl ether beta2 adrenergic receptor agonists |
05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
05/02/2007 | EP1778230A2 Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
05/02/2007 | EP1778227A1 Inhalatory medicaments containing corticosteroids, betamimetic agents, and a novel anticholinergenic agent |
05/02/2007 | EP1778226A1 Aerosol formulation for inhalation, containing an anticholinergenic agent |
05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
05/02/2007 | EP1526870B1 Combination of loteprednoletabonat and dfho for treating respiratory diseases, allergic diseases, asthma and copd |
05/02/2007 | EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
05/02/2007 | EP1441723B1 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension |
05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
05/02/2007 | EP1341542B1 Indanylderivatives for treating airway diseases |
05/02/2007 | EP1202734B1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
05/02/2007 | CN1956979A Thiazole derivative |
05/02/2007 | CN1956978A [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase |
05/02/2007 | CN1956728A Enzymes for pharmaceutical use |
05/02/2007 | CN1956721A Quinazolinone derivatives useful as vanilloid antagonists |
05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
05/02/2007 | CN1954874A Curcuma zedoary oil fat injection and preparation process |
05/02/2007 | CN1954871A Yanhouqing preparation for treating throat disease and its preparation method and quality control method |
05/02/2007 | CN1954858A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954857A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954856A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954854A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954853A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954852A Chinese drugs compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954851A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954850A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954842A Honey polygala root and its preparation method |
05/02/2007 | CN1954841A Medicine for treating chronic pharyngitis |
05/02/2007 | CN1954821A Traditional Chinese composite preparation for treating asthma and its preparation method |
05/02/2007 | CN1954808A High dose Ambroxol hydrochloride freeze-dried preparation and preparation method |
05/02/2007 | CN1954803A Spray-dried granules containing pranlukast and processes for the preparation thereof |
05/02/2007 | CN1313469C Novel derivative of flavone c-glycoside and composition containing the same |
05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
05/02/2007 | CN1313450C Tachykinin receptor antagonists |
05/02/2007 | CN1313448C Metalloproteinase inhibitors |
05/02/2007 | CN1313153C Use of immunoglobulin and cell growth factor in preparing medicine for asthma |
05/02/2007 | CN1313149C Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
05/02/2007 | CN1313142C Pharmaceutical composition with exterior syndrome easing, cough and asthma easing function |
05/02/2007 | CN1313134C External-use traditional Chinese medicine for curing chronic rhinitis, nasosinusitis and laryngopharyngitis and its preparing method |
05/02/2007 | CN1313116C Chinese traditional medicine for treating and preventing asthma in children |
05/02/2007 | CN1313109C Decoction preparation of semen sinapis albae, fructus perillae and semen raphani and its preparing method |
05/02/2007 | CN1313086C Aarin preparation for injection and preparing process thereof |
05/01/2007 | US7211666 N-Cyclopropyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide; aminating with chloramine to produce a pyrrole with a Nitrogen nitrogen bond; reacting with formamide, cyclizing to form the pyrrolotriazine core; kinase inhibitors |
05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
05/01/2007 | US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene |
05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
05/01/2007 | US7211258 Protein A compositions and methods of use |
05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
05/01/2007 | CA2244357C A novel pharmaceutical composition for inhalation containing cr 2039 (andolast) |
05/01/2007 | CA2226934C Ipratropium bromide enantiomer with a prolonged duration of action |
04/26/2007 | WO2007047576A1 Pharmacological treatments for sleep disorders |
04/26/2007 | WO2007047575A2 Pharmacological treatments for sleep-related breathing disorders |
04/26/2007 | WO2007046347A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
04/26/2007 | WO2007045980A1 Compositions of phosphodiesterase type iv inhibitors |
04/26/2007 | WO2007045979A1 Pharmaceutical compositions of muscarinic receptor antagonists |
04/26/2007 | WO2007045389A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
04/26/2007 | WO2007045151A1 Compounds and their pharmaceutical compositions for the treatment of nasal cavum hypersecretion and chronic obstructive pulmonary disease |
04/26/2007 | WO2007045046A1 Treatment of hypersensitivity |
04/26/2007 | WO2006128847A3 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor |
04/26/2007 | WO2006128600A3 Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine |
04/26/2007 | WO2006117300A3 Crystalline forms of tiotropium bromide |
04/26/2007 | WO2006108039A3 Substituted azetidinones |
04/26/2007 | WO2006067165A3 Indolidone derivatives for the treatment or prevention of fibrotic diseases |
04/26/2007 | WO2006066234A3 Compositions and methods for reducing lung volume |
04/26/2007 | US20070093553 HMB compositions and uses thereof |
04/26/2007 | US20070093531 Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them |
04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
04/26/2007 | US20070093510 Phosphodiesterase 4 inhibitors |
04/26/2007 | US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases |
04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
04/26/2007 | US20070092523 Combination Therapy Of Respiratory Diseases Using Antibodies |
04/26/2007 | CA2626692A1 Treatment of hypersensitivity |
04/26/2007 | CA2626628A1 Compositions of phosphodiesterase type iv inhibitors |
04/26/2007 | CA2626612A1 Pharmaceutical compositions of muscarinic receptor antagonists |
04/26/2007 | CA2625341A1 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
04/25/2007 | EP1776962A1 Vaccine |
04/25/2007 | EP1776959A2 Use of HGF for the manufacture of a medicament for treating fibrotic disorders |
04/25/2007 | EP1776336A2 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them |